Nuveen Asset Management, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,556,487
-58.3%
42,665
-49.8%
0.00%
-50.0%
Q2 2023$6,126,986
+128780.6%
84,979
+31.5%
0.00%0.0%
Q1 2023$4,754
+58.2%
64,630
+43.6%
0.00%
+100.0%
Q4 2022$3,006
-99.9%
44,994
-13.3%
0.00%
-50.0%
Q3 2022$4,469,000
-6.1%
51,898
-2.7%
0.00%0.0%
Q2 2022$4,757,000
-22.1%
53,320
-1.6%
0.00%0.0%
Q1 2022$6,109,000
-20.8%
54,168
-2.3%
0.00%0.0%
Q4 2021$7,709,000
-10.7%
55,445
-7.1%
0.00%
-33.3%
Q3 2021$8,637,000
-30.6%
59,677
-37.1%
0.00%
-25.0%
Q2 2021$12,445,000
-15.7%
94,871
-2.1%
0.00%
-20.0%
Q1 2021$14,767,000
+114.8%
96,863
+40.1%
0.01%
+150.0%
Q4 2020$6,876,000
+1.4%
69,137
-2.8%
0.00%
-33.3%
Q3 2020$6,782,000
-17.6%
71,158
-3.4%
0.00%0.0%
Q2 2020$8,235,000
-4.4%
73,629
-37.8%
0.00%
-25.0%
Q1 2020$8,610,000
-24.8%
118,395
+7.9%
0.00%0.0%
Q4 2019$11,443,000
+0.6%
109,715
-4.0%
0.00%
-20.0%
Q3 2019$11,378,000
-13.0%
114,309
-0.3%
0.01%0.0%
Q2 2019$13,081,000
+776.7%
114,596
+942.3%
0.01%
-44.4%
Q4 2018$1,492,000
-52.6%
10,995
-4.2%
0.01%
-47.1%
Q3 2018$3,151,000
+26.4%
11,478
-4.6%
0.02%
+6.2%
Q2 2018$2,492,000
+46.5%
12,028
+16.8%
0.02%
+45.5%
Q1 2018$1,701,000
+34.3%
10,302
+11.4%
0.01%
+37.5%
Q4 2017$1,267,000
-1.9%
9,251
-2.5%
0.01%0.0%
Q3 2017$1,292,000
+70.7%
9,492
+52.2%
0.01%
+60.0%
Q2 2017$757,000
-0.8%
6,236
-13.4%
0.01%0.0%
Q1 2017$763,0007,2050.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders